1. Catalogs
  2. Welch Allyn
  3. RETeval-DR Electroretinograph

RETeval-DR Electroretinograph

RETeval-DR Electroretinograph

RETeval-DR Electroretinograph

Product catalog summary
Introduction
Welch Allyn's RETeval-DR is a non-mydriatic electroretinograph designed to screen for diabetic retinopathy, a leading cause of blindness among working-age adults. The device aims to improve patient management by providing quick and comfortable screenings without the need for pupil dilation.
Key Features
  • Non-Mydriatic Screening: RETeval-DR allows for comfortable screenings without dilation, using a built-in pupilometer to adjust flash intensity.
  • Quick and Efficient: The screening process takes only three minutes, making it suitable for various healthcare settings, including primary care and pharmacies.
  • High Accuracy: The device has a 99.2% negative predictive value and compares favorably with traditional methods in detecting severe non-proliferative diabetic retinopathy (NPDR) or worse.
  • Portable and User-Friendly: Handheld and battery-powered, RETeval-DR is easy to use with minimal training required, providing immediate test results.
Clinical and Economic Benefits
  • Cost-Effective: RETeval-DR offers a lower-cost alternative to traditional dilated eye exams and teleretinal imaging services.
  • Enhanced Patient Satisfaction: The quick and non-invasive nature of the test improves patient throughput and satisfaction.
Technical Specifications
  • Includes disposable sensor strips, charging dock, and USB cable.
  • Operates on a lithium-ion battery with multiple plug types for international use.
Conclusion
The RETeval-DR by Welch Allyn is a significant advancement in diabetic retinopathy screening, offering a simple, efficient, and cost-effective solution for healthcare providers. It aligns with the Welch Allyn Vision For All initiative to reduce preventable blindness through accessible technology.
See more

Catalog excerpts

RETeval-DR Electroretinograph-1

RETeval-DR™ Electroretinograph In just THREE MINUTES, you can screen for diabetic retinopathy WHEREVER PATIENTS RECEIVE CARE. Welch Allyn VISION FOR ALL Diabetic retinopathy is the leading 20 cause of blindness among working-age adults. However, with early detection and treatment, most cases can be prevented. 0 TRAGICALLY, DOCUMENTED COMPLIANCE WITH VISIONSAVING ANNUAL EXAMS IS OFTEN LESS THAN 50%. NON-MYDRIATIC SCREENING IN JUST THREE MINUTES. WITH EARLY DETECTION, 95% OF VISION LOSS CASES CAN BE PREVENTED.

 Open the catalog to page 1
RETeval-DR Electroretinograph-2

Diabetic Retinopathy • Mild Non-Proliferative DR • Moderate Non-Proliferative DR • Severe Non-Proliferative DR • Proliferative DR • Clinically Significant Macular Edema Absent CSME, mild to moderate NPDR is typically not treated with laser or anti-VEGF therapy.* ‘ American Academy of Ophthalmology Diabetic Retinopathy Preferred Practice Guidelines 2014, Table-6. RETeval-DR is designed for healthcare providers who want t RETeval-DR effectively screens for vision-threatening diabetic retinopa NON-MYDRIATIC FOR COMFORT Dilated retinal examinations can be uncomfortable, time-consuming and sometimes...

 Open the catalog to page 2
RETeval-DR Electroretinograph-3

PRIMARY CARE PHARMACY OUTREACH t to improve management of their patients with diabetes.pathy with a 99.2% negative predictive value.1 LOWER SCREENING COSTS Compared to dilated eye exams and teleretinal imaging services that require costly fundus cameras, RETeval-DR offers healthcare systems and providers an effective way to screen for vision-threatening diabetic retinopathy at a lower cost. EFFICIENT FOR EYE CARE Fast, non-mydriatic RETeval-DR electroretinograph technology augments traditional diabetic retinopathy screening techniques. It enables busy eye care specialists to more efficiently...

 Open the catalog to page 3
RETeval-DR Electroretinograph-4

How Welch Allyn RETeval-DR Serves You Better TRUSTED GLOBAL BRAND For 100 years, Welch Allyn has brought a unique perspective to developing diagnostic solutions by combining pragmatic knowledge with a visionary spirit of innovation. Whether you have one office or are managing a national program, Welch Allyn has the talent and resources to scale and match your requirements. UNIQUE ELECTRORETINOGRAPH (ERG) TECHNOLOGY MADE SIMPLE ERG is an instrument for measuring the electrical response of the retina to light stimulation —a fundus image is not required. Similar to an ECG, electrical activity of...

 Open the catalog to page 4

All Welch Allyn catalogs and technical brochures

Archived catalogs

  1. ABPM 6100

    4  Pages

  2. Durashock

    2  Pages

  3. ABPM 7100

    12  Pages

  4. RetinaVue700

    180  Pages

  5. SureTemp® Plus

    34  Pages

  6. Insight™

    2  Pages

  7. KleenSpec®

    3  Pages

  8. Connex VM

    4  Pages

  9. EpiScope

    2  Pages

  10. LumiView?

    3  Pages

*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.